MK-677 (Ibutamoren) (10mg/capsule) 60 Capsules

Description

What Is MK-677 (Ibutamoren)?

MK-677, also known as ibutamoren, is a potent, orally active growth hormone secretagogue that mimics the signaling of ghrelin, the endogenous hunger hormone, at the growth hormone secretagogue receptor (GHS-R1a). Unlike exogenous growth hormone injections, MK-677 stimulates the pituitary gland to increase pulsatile secretion of endogenous growth hormone (GH) and insulin-like growth factor 1 (IGF-1) without suppressing the hypothalamic-pituitary axis.

First developed by Merck in the late 1990s, ibutamoren has been studied extensively in clinical trials for age-related muscle wasting, bone density loss, sleep quality improvement, and metabolic regulation. Its oral bioavailability and long elimination half-life of approximately 24 hours make it one of the most convenient GH secretagogues available for research applications. MK-677 remains a non-peptide compound, distinguishing it structurally from GHRPs such as GHRP-6 and hexarelin, and offering superior stability compared to injectable secretagogues.

Key Features and Specifications

Mechanism of Action: How MK-677 Works

MK-677 functions as a ghrelin receptor agonist, binding to GHS-R1a in the hypothalamus and pituitary gland. This binding triggers a signaling cascade that amplifies the natural pulsatile release of growth hormone from somatotroph cells. Importantly, ibutamoren increases GH secretion without significantly elevating cortisol, a critical differentiator from many other secretagogues that can disrupt adrenal function.

The compound elevates circulating GH levels by approximately 40 to 80 percent at standard research doses, with corresponding increases in IGF-1 of 39 to 89 percent observed over 2 to 12 weeks of continuous administration. MK-677 also enhances REM sleep duration by modulating GH secretion patterns during the early phases of the sleep cycle, a mechanism that has drawn interest from researchers studying age-related sleep architecture deterioration.

Unlike direct GH administration, ibutamoren preserves the natural feedback loops between GH, IGF-1, and somatostatin, meaning the body retains its ability to regulate secretion amplitude. This characteristic makes it especially valuable in longitudinal research protocols where maintaining physiological signaling patterns is essential.

Reported Research Applications and Benefits

Peer-reviewed studies investigating MK-677 have documented several areas of interest that continue to drive its use in preclinical and translational research settings. Growth hormone elevation research represents the primary application, with ibutamoren consistently demonstrating the ability to raise GH and IGF-1 levels across diverse populations including elderly subjects, obese individuals, and those with relative GH deficiency.

Bone mineral density research has shown that MK-677 increases markers of bone turnover, including osteocalcin and type I collagen cross-linked C-telopeptide, suggesting potential applications in osteoporosis and fracture healing models. A two-year clinical study in postmenopausal women demonstrated significant increases in femoral neck bone mineral density after 12 months of daily administration.

Body composition studies indicate that ibutamoren promotes lean mass accretion while reducing adipose tissue accumulation, effects attributed to the anabolic properties of sustained GH and IGF-1 elevation. Sleep quality research has revealed that MK-677 increases Stage IV sleep duration by approximately 50 percent and REM sleep duration by roughly 20 percent, effects that persist even during prolonged administration periods.

MK-677 Dosage Information for Research

MK-677 is typically administered once daily in the evening to coincide with the natural nocturnal growth hormone pulse. Its 24-hour half-life ensures stable plasma concentrations throughout the dosing interval. Research protocols frequently note that GH and IGF-1 levels reach a steady state within one to two weeks of continuous daily dosing, with peak IGF-1 elevation typically observed between weeks four and eight.

MK-677 vs Sermorelin: Key Differences

Storage and Handling Instructions

Store MK-677 capsules at controlled room temperature between 20°C and 25°C (68°F to 77°F) in the original sealed container. Keep the product in a cool, dry environment away from direct sunlight, excessive heat, and moisture. Capsules should remain in their original packaging until use to maintain stability. Under proper storage conditions, MK-677 capsules maintain full potency for a minimum of 24 months from the date of manufacture. Do not freeze.

Why Choose PrymaLab MK-677 Ibutamoren Capsules

Every batch of PrymaLab MK-677 undergoes rigorous third-party testing by independent, accredited laboratories using high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to verify identity, purity, and potency. Each order ships with a batch-specific Certificate of Analysis (COA) documenting ≥99% purity, absence of heavy metals, residual solvents, and microbial contaminants.

PrymaLab uses pharmaceutical-grade encapsulation processes to ensure precise 10 mg dosing in each capsule, eliminating the variability common with liquid formulations. Our GMP-compliant manufacturing and full lot traceability provide the consistency and reliability that serious research demands. Free priority shipping is included on all domestic orders.

Frequently Asked Questions About MK-677

What is the recommended MK-677 dosage for beginners?

Most published research protocols begin with 10 mg per day administered as a single oral dose in the evening. This starting dose allows researchers to assess individual subject response before considering dose escalation to 25 mg per day, which represents the most commonly studied dose in clinical trials. The 24-hour half-life permits once-daily dosing.

How long does it take for MK-677 to elevate GH and IGF-1 levels?

Growth hormone levels typically increase within the first dose, with acute elevations measurable within two to four hours of administration. IGF-1 levels require longer to reach steady state, generally achieving peak elevation between weeks four and eight of continuous daily dosing. Consistent administration is essential for sustained physiological effects.

Does MK-677 suppress natural growth hormone production?

MK-677 does not suppress endogenous GH production because it works by amplifying the body’s own pulsatile GH release mechanism rather than introducing exogenous hormone. The hypothalamic-pituitary feedback axis remains intact, meaning natural regulatory processes continue to function during and after administration.

How does MK-677 compare to injectable GH secretagogues like GHRP-6?

MK-677 offers the convenience of oral administration with a 24-hour half-life, compared to GHRP-6 which requires multiple daily subcutaneous injections and has a half-life of approximately 15 to 20 minutes. Both compounds stimulate GH release, but ibutamoren provides more stable plasma concentrations and does not require reconstitution or cold chain storage.

What is the half-life of MK-677 (ibutamoren)?

The ibutamoren elimination half-life is approximately 24 hours based on pharmacokinetic data from clinical studies. This extended half-life supports once-daily oral dosing and maintains consistent GH secretagogue activity throughout the 24-hour period, aligning with natural circadian GH pulsatility patterns.

Quality Assurance and Testing

PrymaLab maintains a zero-compromise quality standard for all MK-677 products. Each production batch is tested using HPLC for purity determination and mass spectrometry for structural identity confirmation. Independent third-party laboratories conduct all testing, and results are documented in a batch-specific Certificate of Analysis that accompanies every order. Our quality program includes heavy metal screening, residual solvent analysis, microbial testing, and endotoxin evaluation to ensure every capsule meets pharmaceutical research-grade standards.

Research Disclaimer

MK-677 (ibutamoren) is sold strictly for laboratory research and scientific investigation purposes only. This product is not intended for human consumption, veterinary use, or therapeutic application. MK-677 has not been approved by the FDA or any regulatory agency for medical use. Purchasers must be qualified researchers affiliated with accredited institutions or licensed research organizations. By purchasing this product, you confirm that it will be used exclusively in accordance with all applicable local, state, and federal regulations governing research materials.